UCLA research could lead to a simple saliva test capable of diagnosing — at an early stage — diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.
The study, the most comprehensive analysis ever conducted of RNA molecules in human saliva, reveals that saliva contains many of the same disease-revealing molecules that are contained in blood. It was published online today by the peer-reviewed journal Clinical Chemistry and will be published in the journal’s January 2015 special print issue, “Molecular Diagnostics: A Revolution in Progress.”
“If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer — and we can utilize this knowledge for personalized medicine,” said Dr. David Wong, a senior author of the research and UCLA’s Felix and Mildred Yip Endowed Professor in Dentistry.
Wong said the test also holds promise for diagnosing Type 2 diabetes, gastric cancer and other diseases. “If you don’t look in saliva, you may miss important indicators of disease,” Wong said. “There seems to be treasure in saliva, which will surprise people.”
RNA, widely known as a cellular messenger that makes proteins and carries out DNA’s instructions to other parts of the cell, is now understood to perform sophisticated chemical reactions and is believed to perform an extraordinary number of other functions, at least some of which are unknown.
Wong’s research over the past decade has focused on identifying biomarkers in saliva. His laboratory discovered that some of the same RNA that is inside human cells are also present in saliva and can be used to detect diseases — a surprising finding, he said, because enzymes in saliva can degrade RNA, making the mouth “a hostile environment.”
The new research is a collaboration with Xinshu (Grace) Xiao, the paper’s other senior author and a UCLA associate professor of integrative biology and physiology in the UCLA College. Using state-of-the-science genomics and bioinformatics, the researchers analyzed 165 million genetic sequences.
Among the many forms of RNA are some unusual ones that live in the mouth and in cells. For example, it wasn’t known until very recently that RNA comes in a circular form; the linear form has long been known. But the UCLA scientists identified more than 400 circular RNAs in human saliva — the first discovery of circular RNA in saliva or any body fluid — including 327 forms that were previously unknown.
Circular RNA’s function in saliva is not entirely understood, although it does serve as a sponge for tiny RNA molecules called microRNAs, which bind to it.
“Circular RNAs in saliva may be protecting other RNAs,” said Xiao, who also is a member of UCLA’s Molecular Biology Institute. It’s likely, she said, that circular RNAs in saliva protect microRNAs from being degraded.
MicroRNAs, which once seemed to be little more than molecular noise, play important roles in many cell types, and have been implicated in cancers and other diseases, Xiao said. One microRNA can regulate hundreds of genes, she said.
The scientists compared microRNA levels in saliva to those in the blood and other body fluids, and found the levels of microRNA in blood and in saliva are very similar — indicating that a saliva sample would be a good measure of microRNAs in the body.
They also found that saliva contains another class of small RNAs, called piwi-interacting RNAs, or piRNAs, which are produced by stem cells, skin cells and germ cells. There are very few piRNAs in blood and most other body fluids, but Xiao’s analysis showed that piRNA are abundant in saliva. Although their function is not yet known, Xiao said they may protect the body from viral infection.
While most RNA molecules translate genetic code from DNA to make proteins, there is also a class called non-coding RNAs that does not.
“Saliva carries with it non-coding RNAs, microRNAs, piRNAs and circRNAs that are biomarkers for disease and health monitoring,” said Wong, who also is associate dean of research at the UCLA School of Dentistry. “Had we not done this collaboration, we would never know that non-coding RNAs, microRNAs, piRNAs and circRNAs exist in saliva.”
Their overriding conclusion is that saliva has tremendous medical and scientific value. In the not-too-distant future, dentists might be able to take saliva samples to analyze for a variety of diseases. And, Wong says, the research could lead to a new category of self-diagnostic devices. “This could indicate that wearable gear that informs you whether you have a disease — even before you have any symptoms — is almost here,” he said.
The Latest on: Molecular diagnostics
via Google News
The Latest on: Molecular diagnostics
- Co-Diagnostics nets European approval for its coronavirus PCR teston February 25, 2020 at 9:18 am
RELATED: Co-Diagnostics receives CE mark for Zika screening test The molecular diagnostic test searches for RNA linked to the coronavirus strain using a real-time RT-PCR kit aimed at conserved regions ...
- Rising Cancer Prevalence Driving Molecular Cytogenetics Market Growthon February 25, 2020 at 7:39 am
Inquiry before purchase of this [email protected] http://bit.ly/2VwKUqn Secondly, the advancements in molecular cytogenetic techniques have revolutionized the field of diagnostics. The automation of the ...
- In Vitro Diagnostics Market 2020 : Revenue Growth Analysis and Top Companieson February 25, 2020 at 7:39 am
The large share of this segment can be attributed to the rising prevalence of infectious diseases as well as multi-drug-resistant infectious diseases across the globe and the growing need for ...
- Molecular Diagnostics Market Analysis By Industry Size, Share, Revenue Growth, Development And Demand Forecast To 2025on February 25, 2020 at 7:11 am
Feb 25, 2020 (AmericaNewsHour) -- Kenneth Research has published a detailed report on Molecular Diagnostics Market which has been categorized by market size, growth indicators and encompasses detailed ...
- In Vitro Diagnostics Market Size Worth $85.8 Billion by 2027 | CAGR: 4.4%: Grand View Research, Inc.on February 25, 2020 at 7:02 am
market is expected to reach USD 85.8 billion by 2027, according to a new report by Grand View Research, Inc. It is projected to exhibit a 4.4% CAGR over the forecast period. Development of simplified ...
- Co-Diagnostics (NASDAQ:CODX) Helping to Mitigate Global Economic Riskon February 24, 2020 at 3:00 pm
New York City, Feb. 18, 2020 (GLOBE NEWSWIRE) -- As the world continues to worry about the novel coronavirus Covid-19 and investors begin to understand the potential impact this fast-spreading ...
- Oncology Based Molecular Diagnostics Market Research Report 2019-2025: By Product, Application, Manufacturer, Sales and Segmentationon February 23, 2020 at 11:05 pm
The report provides rational insights along with historical and forecast data to said in better understanding of the Global Oncology Based Molecular Diagnostics Market. The report provides a ...
- Sepsis Diagnostics Market Growing at CAGR of 9.1% from 2018-2023 | Driver, Restraint, Leading Companieson February 21, 2020 at 6:13 pm
These devices are easy to use, fast, and have advanced features, owing to which they cost more as compared to conventional blood culture tests. For instance, the cost of molecular diagnostic tests is ...
- Molecular Cancer Diagnostics Market Insights, 2019 to 2025 - Industry Developments, Technologies, Products, Regions, and Competitorson February 21, 2020 at 3:53 am
DUBLIN, Feb. 21, 2020 /PRNewswire/ -- The "Molecular Cancer Diagnostics Market" report has been added to ResearchAndMarkets.com's offering. This report contains market sizing and forecasts for this ...
- Molecular Cancer Diagnostics Industry Overview and Forecast to 2025on February 21, 2020 at 12:58 am
Dublin, Feb. 21, 2020 (GLOBE NEWSWIRE) -- The "Molecular Cancer Diagnostics Market" report has been added to ResearchAndMarkets.com's offering. This report contains market sizing and forecasts for ...
via Bing News